comprehensive -WSS

comprehensive

author：knowledge 2025-09-28 00:48:45 - browse：328

Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： With Wegovy coverage, Medicare patients may face high costs

hotspot

WSS

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

J&J to emphasize cancer drugs, stop much of its vaccine research

6 surprising facts about sugar

With Wegovy coverage, Medicare patients may face high costs

The EPA's new lead rule: How one expert crunched the numbers

Readout LOUD podcast, live from the STAT Breakthrough Summit East

focus

comprehensive

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Takeda, Janssen join wearable maker to measure scratching

How one medical school became remarkably diverse

Mirador, a new biotech startup, launches with $400 million

Novavax promises a turnaround & Lilly roils the obesity market

How to pay for weight loss drugs and save Medicare

How to save PrEP access — and even expand it

30 years of 'Listening to Prozac'

Sports medicine is finally prioritizing gender equality

Medical devices makers are asking for forgiveness, not permission

Wikipedia

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Adam's Take: Intra

Pfizer, Moderna say biotech, pharma drug development is a sprint

As biotech industry slumps, bioscience job market is upside down

Cigna, Humana reportedly in talks to merge

Adam's Take: Intra

Wikipedia

hotspot

leisure time

explore